SECOND AMENDMENT TO LEASELease • March 12th, 2008 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances
This SECOND AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 21st day of December, 2007 by and between OYSTER POINT TECH CENTER, LLC, a Delaware limited liability company (“Landlord”), and MONOGRAM BIOSCIENCES, INC., a Delaware corporation (“Tenant”).
CONSENT TO FOURTH SUBLEASE AMENDMENTSublease Amendment • March 12th, 2008 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances
This Consent to Fourth Sublease Amendment (this “Consent”) is made as of October 12, 2007, by and among ARE-TECHNOLOGY CENTER SSF, LLC, a Delaware limited liability company (“Landlord”), DIADEXUS, INC., a Delaware corporation (“New Tenant”), and MONOGRAM BIOSCIENCES, INC., a Delaware corporation (“Sublessee”), formerly known as VIROLOGIC, INC., with reference to the following Recitals.
FOURTH AMENDMENT TO SUBLEASESublease • March 12th, 2008 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances
THIS FOURTH AMENDMENT TO SUBLEASE (this “Fourth Amendment”), dated October 12, 2007, is entered into by and between DIADEXUS, INC., a Delaware corporation (“Sublandlord”), and MONOGRAM BIOSCIENCES, INC., a Delaware corporation (“Subtenant”).
FIRST AMENDMENT TO LEASELease • March 12th, 2008 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances
This FIRST AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 5th day of October, 2007 by and between OYSTER POINT TECH CENTER, LLC, a Delaware limited liability company (“Landlord”), and MONOGRAM BIOSCIENCES, INC., a Delaware corporation (“Tenant”).
SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 12th, 2008 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances • Illinois
THIS SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this “Agreement”) is entered into this 19th day of December, 2007, by and between MONOGRAM BIOSCIENCES, INC., a Delaware corporation (“Borrower”) and MERRILL LYNCH CAPITAL, a division of Merrill Lynch Business Financial Services Inc., individually as a Lender, and as Agent (“Agent”).
